###begin article-title 0
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
Role of the ENPP1 K121Q Polymorphism in Glucose Homeostasis
###end article-title 0
###begin p 1
###xml 39 55 39 55 <email xmlns:xlink="http://www.w3.org/1999/xlink">lfritti@unict.it</email>
Corresponding author: Lucia Frittitta, lfritti@unict.it
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
OBJECTIVE- To study the role of the ENPP1 Q121 variant on glucose homeostasis in whites from Italy.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 175 183 <span type="species:ncbi:9606">children</span>
RESEARCH DESIGN AND METHODS- We conducted case-control studies in 764 adults (from two independent samples of 289 nonobese and 485 obese individuals) and 240 overweight/obese children undergoing oral glucose tolerance testing (OGTT). Early-phase insulin secretion and insulin sensitivity (the insulinogenic index and the insulin sensitivity index) and their interplay (the disposition index) were calculated.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 87 89 87 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 178 180 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 291 292 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 303 305 299 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 329 330 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 341 343 335 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 448 449 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 460 462 454 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 543 544 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 553 555 547 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 566 568 560 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 624 625 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 634 636 628 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 823 824 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 833 835 827 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 846 848 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 887 888 881 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 897 899 891 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 910 912 904 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 673 681 <span type="species:ncbi:9606">children</span>
RESULTS- In adult subjects, glucose profiles during OGTT were significantly (P = 2 x 10-2) different across K121Q genotype groups and higher in QQ than KK individuals (P = 5 x 10-2). The insulinogenic index was significantly reduced in QQ (18.5 +/- 3.4) compared with both KK (31.6 +/- 1.0; P = 2.2 x 10-7) and KQ (30.5 +/- 1.5; P = 3.2 x 10-6) individuals. KQ individuals also showed a reduced insulin sensitivity index compared with KK subjects (P = 3.6 x 10-2). The disposition index was lower in QQ carriers than in KQ and KK individuals (P = 8 x 10-3 and 4 x 10-4, respectively) and lower in KQ than in KK individuals (P = 3 x 10-2). Data obtained in overweight/obese children were very similar to those observed in adults, with QQ individuals showing (compared with KQ and KK subjects) a reduced insulinogenic index (P = 7 x 10-3 and 2 x 10-2, respectively) and disposition index (P = 2 x 10-2 and 7 x 10-3, respectively).
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
CONCLUSIONS- Homozygous carriers of the ENPP1 Q121 variant are characterized by an altered glucose homeostasis. Reduced early-phase insulin secretion and inefficient interplay between insulin secretion and sensitivity, which occur at early ages, are major determinants of this defect.
###end p 6
###begin p 7
Published ahead of print at  on 5 September 2008.
###end p 7
###begin p 8
V.T. and L.F. equally supervised the study.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 394 395 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 683 684 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
Insulin resistance and inadequate insulin secretion are pathogenic for type 2 diabetes (1). Insulin-resistant subjects who eventually develop type 2 diabetes maintain normal or near-normal glycemia for many years because of compensatory hyperinsulinemia (2). Type 2 diabetes eventually ensues only when beta-cells fail to secrete sufficient insulin to adequately counteract insulin resistance (3). Thus, an inefficient interplay between insulin secretion and sensitivity is the key pathogenic factor for developing type 2 diabetes. In agreement with this tenet, the disposition index (the product of insulin secretion x insulin sensitivity) is the best predictor of type 2 diabetes (4).
###end p 10
###begin p 11
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 576 577 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1158 1163 1158 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 972 984 <span type="species:ncbi:9606">participants</span>
Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) (5) downregulates insulin signaling by direct inhibition of insulin receptor signaling (6-8). We previously described an ENPP1 missense polymorphism (K121Q, rs1044498) (9). Compared with the more common K121, the Q121 variant is a stronger inhibitor of insulin receptor signaling in cultured cells (7,9) and has been associated in most, although not all, studies with insulin resistance-related abnormalities (5,6). Several groups have investigated whether the Q121 variant is also associated with type 2 diabetes (5,6). Although results have not been homogeneous across studies, a recent and comprehensive meta-analysis has concluded that Europeans who are homozygous for the Q121 allele (i.e., carrying the QQ genotype) have a 38% increased risk of type 2 diabetes (10). More recently, the Q121 allele has been reported to be associated with hyperglycemia and insulin resistance in 2,511 Framingham Heart Study participants (11). To gain insight about the mechanisms underlying these associations, we studied insulin secretion, insulin sensitivity, and their interplay in whites from Italy across ENPP1 K121Q genotype groups.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin p 13
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 47 52 <span type="species:ncbi:9606">child</span>
###xml 489 495 <span type="species:ncbi:9606">People</span>
A total of 764 adult (age 18-70 years) and 240 child (age 8-17 years) unrelated subjects from Eastern Sicily, with fasting plasma glucose <7.0 mmol/l and not taking medications known to interfere with glucose and lipid metabolism, were recruited at the Endocrine Unit of Garibaldi Hospital (Catania, Italy) (see Methods in the online appendix [available at ] for details of their clinical characteristics, the study design, and oral glucose tolerance testing [OGTT]-derived measurements). People from Eastern Sicily have been reported to be genetically homogeneous (12), which is a feature that minimizes the risk of population stratification.
###end p 13
###begin p 14
###xml 189 200 <span type="species:ncbi:9606">participant</span>
###xml 227 232 <span type="species:ncbi:9606">child</span>
The study protocol was approved by the institutional review board and performed according to the dictates of the Helsinki Declaration. Written informed consent was obtained from each adult participant and from a parent of each child.
###end p 14
###begin title 15
Genotyping.
###end title 15
###begin p 16
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
DNA was extracted from whole blood by standard methods. Genotyping was performed by restriction fragment-length polymorphism (9), with a failure rate <1%. Genotyping quality was checked by directly sequencing 10% of randomly selected samples. The agreement rate of resequenced samples was >99%. The proportion of the K121Q genotypes was in Hardy-Weinberg equilibrium in both samples studied.
###end p 16
###begin title 17
Statistical analysis.
###end title 17
###begin p 18
###xml 413 415 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 681 682 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 884 885 880 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 329 336 <span type="species:ncbi:9606">patient</span>
Data are provided as means +/- SEM. All the analyses are adjusted for age, sex, and BMI. Continuous variables were compared between groups using one-way or repeated-measurements ANCOVA. In particular, repeated-measurements ANCOVA models to assess differences over time were carried out via hierarchical linear models, and within-patient correlation was accounted for with an unstructured correlation type matrix (13). Simple and multiple regression models were used to test for correlations between continuous variables. The interaction between genotype and BMI in modulating OGTT-derived indexes was tested by the general linear model analysis after adjusting for age and sex. chi2 was used to test for association between categorical variables and genotypes and to test the Hardy-Weinberg equilibrium as well. Variables not normally distributed were log transformed for analyses. A P value <0.05 was considered significant. All analyses were performed using SPSS (version 15.0; SPSS, Chicago, IL) and SAS (release 9.1; SAS Institute, Cary, NC).
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
Adult subjects
###end title 20
###begin title 21
Baseline characteristics.
###end title 21
###begin p 22
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 147 154 147 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 317 324 317 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
Clinical baseline characteristics of nonobese and obese subjects pooled together and stratified according to the ENPP1 K121Q genotype are shown in Table 1. Fasting plasma glucose was associated with the Q121 variant and was higher in QQ individuals. Data are also given separately for nonobese and obese individuals (Table 1 of the online appendix).
###end p 22
###begin title 23
Glucose and insulin profiles during OGTT.
###end title 23
###begin p 24
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 153 166 153 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic> and <italic>B</italic></xref>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 318 320 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 521 522 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 535 537 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 546 547 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 540 547 540 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 649 651 649 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 803 804 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 815 817 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 826 827 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 820 827 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 921 922 921 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 931 933 931 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 962 964 962 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
In both nonobese and obese individuals, plasma glucose levels tended to be different across genotype groups, with QQ carriers showing the worst profile (Fig. 1A and B, respectively in the online appendix), which reached statistical significance in the obese group (age-, sex-, and BMI-adjusted overall P value 4.8 x 10-2). Because glucose profiles across genotypes were similar in the two groups, data were pooled and analyzed together. Plasma glucose levels during OGTT were different across genotypes (adjusted overall P value 2 x 10-2) (Fig. 1A). At post hoc analysis, the glucose profile was higher in QQ than in KK carriers (adjusted P = 5 x 10-2). Although no significant difference was observed in insulin profiles across genotype groups, a clear genotype-time interaction was observed (adjusted P = 2.6 x 10-3) (Fig. 1B). As a matter of fact, plasma insulin levels at 30 min were lower in QQ than in KQ (adjusted P = 2 x 10-4) and KK (adjusted P = 4 x 10-5) carriers.
###end p 24
###begin title 25
Insulin secretion and sensitivity.
###end title 25
###begin p 26
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 137 139 137 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 142 149 142 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 272 273 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 284 286 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 319 320 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 331 333 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 427 428 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 441 443 435 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 535 536 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 547 549 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 643 644 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 637 644 625 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 718 719 706 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 734 736 722 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 902 903 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 912 914 894 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 925 927 907 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 992 993 974 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1002 1004 984 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1013 1014 995 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1007 1014 989 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>E</italic></xref>
First-phase insulin secretion, as indicated by the insulinogenic index, was different across genotypes (adjusted overall P value 1.2 x 10-6) (Fig. 1C). At post hoc analysis, the insulinogenic index was reduced in QQ (18.5 +/- 3.4) compared with KK (31.6 +/- 1.0; adjusted P = 2.2 x 10-7) and KQ (30.5 +/- 1.5; adjusted P = 3.2 x 10-6) individuals. The insulin sensitivity index was different across genotypes (adjusted overall P value 5 x 10-3). At post hoc analysis, insulin sensitivity index was reduced in KQ (4.3 +/- 0.2; adjusted P = 3.6 x 10-2) but not QQ individuals (5.1 +/- 1.1) compared with that of KK (4.9 +/- 0.2) subjects (Fig. 1D). The disposition index was different across genotypes (adjusted overall P value 7.9 x 10-5). At post hoc analysis, the disposition index was lower in KQ (142.9 +/- 13.4) and QQ (97.2 +/- 28.7) compared with that of KK (166.6 +/- 9.8) individuals (adjusted P = 3 x 10-2 and 4 x 10-4, respectively) and lower in QQ than in KQ individuals (adjusted P = 8 x 10-3) (Fig. 1E).
###end p 26
###begin title 27
Gene-BMI interaction.
###end title 27
###begin p 28
###xml 119 120 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 129 132 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;10</sup>
###xml 303 304 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 315 317 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 370 376 358 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 480 481 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 521 522 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
In the whole sample, insulin sensitivity index was inversely related to BMI (beta value for log-transformed BMI -8.40; P < 1 x 10-10). The linear slope was steeper in QQ (beta = -11.68) than in KK (beta = -8.95) or KQ (beta = -6.86) individuals, indicating a gene-BMI interaction (age- and sex-adjusted P = 5.6 x 10-3) in modulating insulin sensitivity (online appendix Fig. 2). In contrast, no gene-BMI interaction was observed in modulating either insulinogenic index (adjusted P = 0.72) or disposition index (adjusted P = 0.50).
###end p 28
###begin title 29
###xml 17 25 <span type="species:ncbi:9606">children</span>
Overweight/obese children.
###end title 29
###begin p 30
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 103 105 103 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 131 138 131 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 483 485 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 569 571 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 574 581 574 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 788 789 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 798 800 798 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 811 813 811 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 836 837 836 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 830 837 830 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 862 863 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 872 874 872 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 885 887 885 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 910 911 910 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 904 911 904 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>E</italic></xref>
In subjects carrying the KQ genotype, baseline fasting plasma insulin was higher (adjusted P = 1.5 x 10-2) than in KK individuals (Table 1). Although not reaching a nominal statistical significance with the present sample size (P = 0.21), plasma glucose levels during OGTT tended to be different across K121Q genotype groups, with QQ individuals showing the worst profile (Fig. 2A). Plasma insulin levels during OGTT were different across genotypes (adjusted overall P value 3.5 x 10-3) and higher, at post hoc analysis, in KQ than in KK subjects (adjusted P = 2.4 x 10-3) (Fig. 2B). Insulin secretion and sensitivity data obtained in this sample were very similar to those observed in adults, with QQ individuals showing, compared with KQ and KK subjects, a reduced insulinogenic index (P = 7 x 10-3 and 2 x 10-2, respectively) (Fig. 2C) and disposition index (P = 2 x 10-2 and 7 x 10-3, respectively) (Fig. 2E).
###end p 30
###begin title 31
DISCUSSION
###end title 31
###begin p 32
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 1146 1148 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 1521 1523 1521 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
Here, we report that adult whites carrying the ENPP1 Q121 variant show altered glucose homeostasis during OGTT due to an inefficient interplay between insulin secretion and insulin sensitivity (i.e., a reduced disposition index). In hyperglycemic individuals, disposition index may be reduced because of reduced insulin secretion, insulin resistance, or both. Our data show that QQ carriers have impaired first-phase insulin secretion, which entirely account for their reduced disposition index. Conversely, the reduction of disposition index in KQ subjects, who have a perfectly normal first-phase insulin secretion, is entirely due to insulin resistance. The insulin sensitivity index was not reduced in QQ individuals as a whole. It should be considered that insulin resistance inferred from increased endogenous insulin levels (as done in our case) may be underestimated in individuals with reduced insulin secretion such as QQ carriers seem to be. We observed a significant genotype-BMI interaction in determining insulin sensitivity, which is in line with other evidence showing such interaction in modulating the risk of hyperinsulinemia (14), atherosclerosis (15), and type 2 diabetes (16,17). Based on the linear slopes indicating the relationships between insulin sensitivity index and BMI across genotype groups, it appears that QQ individuals tend to have a reduced insulin sensitivity index among frankly obese, but not among lean, subjects. This may be due to the protective role of the QQ genotype on BMI (18), which, when successfully operating (as it is in lean individuals), is likely to preserve insulin sensitivity. We hypothesize that among lean individuals, in the absence of a coexistent reduction of insulin sensitivity, the defective first-phase insulin secretion observed in QQ individuals is not sufficient by itself to increase the risk of type 2 diabetes. In contrast, in the presence of an obesogenic background, the deleterious effect of the Q121 variant on insulin secretion is added on top of that exerted on insulin sensitivity, thus eventually increasing the risk of type 2 diabetes.
###end p 32
###begin p 33
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
Overall, the novel findings of our study are that 1) the ENPP1 Q121 variant affects insulin secretion; 2) for this effect to be evident, the homozygous state is necessary; and 3) the homozygous state is also necessary for a strong deleterious effect on glucose homeostasis and disposition index, which, in fact, are significantly worse in QQ than in KQ subjects. These data perfectly fit with, and possibly explain, the increased risk of type 2 diabetes of QQ (but not KQ) individuals described by a large meta-analysis comprising all studies thus far published in whites (10).
###end p 33
###begin p 34
###xml 165 167 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 257 259 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 302 304 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 505 507 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 558 560 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 605 606 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 607 608 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 618 619 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 633 634 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
Our findings suggest a role of altered insulin signaling in increasing the risk of type 2 diabetes as well as having a direct negative effect on beta-cell function (19). As a matter of fact, cultured beta-cells and animals with deficient insulin receptors (20) or insulin receptor substrate-1 (IRS-1) (21) have reduced insulin secretion. This defect is mainly mediated by the impaired insulin stimulation of the downstream phosphatidylinositol 3-kinase (PI3-K) activity, which alters vesicle trafficking (22) and the release of intracellular calcium stores (21). Insulin stimulation of insulin receptors (7,9), IRS-1 (7), and PI3-K (7) activation is clearly reduced in nonpancreatic cells carrying the Q121 variant. Thus, although the suggestion is entirely speculative, altered beta-cell function in Q121 carriers might be secondary to defective activation of the insulin receptor/IRS-1/PI3-K signaling pathway.
###end p 34
###begin p 35
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 212 220 <span type="species:ncbi:9606">children</span>
A second important finding of our study is that reduced first-phase insulin secretion and the inefficient interplay between insulin secretion and sensitivity occur at early ages in obese QQ individuals. Although children of normal weight would have been an interesting group to examine in order to investigate the role of the Q121 variant on glucose homeostasis, our present finding is, nonetheless, of clinical importance given the recent emergence of hyperglycemia in the early stage of life (23).
###end p 35
###begin p 36
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 767 771 763 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPAR</italic>
###xml 851 853 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
The rs7767502 single nucleotide polymorphism, which is in perfect linkage disequilibrium with K121Q (r2 = 1), was not associated with either the insulinogenic index or the homeostasis model assessment of insulin resistance index (P = 0.47 and 0.34, respectively) among Scandinavians in the Diabetes Genetics Initiative (DGI) () (24). Several factors may underlie this apparent discrepancy. First, the DGI did not evaluate the recessive genetic model, which is clearly accounting for defective insulin secretion in our population. In addition, some heterogeneity in the diabetogenic effect of the Q121 variant has been reported among whites (10). A similar heterogeneity among Europeans has also been reported for the peroxisome proliferator-activated receptor gamma (PPARgamma) P12A polymorphism, a well-established genetic marker of type 2 diabetes (25). Thus, a population specific effect cannot be excluded a priori and should be formally tested in further multicenter studies. Unfortunately, neither insulin sensitivity index nor disposition index values are available in the DGI database.
###end p 36
###begin p 37
###xml 116 117 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 303 311 <span type="species:ncbi:9606">children</span>
The risk of false positive results can affect the genetic investigation of complex traits. Thus, despite the strong P values observed (i.e., in the range of the genome-wide significance for glucose profiles and early insulin secretion), the very similar results obtained in a cohort of overweight/obese children, the genetic homogeneity of the samples studied (12), and the clear consistency with the risk of type 2 diabetes reported in QQ individuals (10) render unlikely a false positive result. Our present findings have to be formally replicated in independent cohorts before they can be considered definitive.
###end p 37
###begin p 38
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
In conclusion, carriers of the ENPP1 Q121 variant, especially in the homozygous state, show altered glucose homeostasis. Reduced first-phase insulin secretion and an inefficient interplay between insulin secretion and sensitivity, which occur at early ages, are major determinants of this defect and are likely to play a role also in the increased risk of type 2 diabetes displayed by these individuals (10).
###end p 38
###begin title 39
Supplementary Material
###end title 39
###begin title 40
Online-Only Appendix
###end title 40
###begin p 41
This study was supported by grants from the Italian Ministry of University and Research (PRIN 2005 to L.F.), the University of Catania (2005 and 2006 to L.F.), and the Italian Ministry of Health (Ricerca Finalizzata 2006 and Ricerca Corrente 2007 and 2008 to S.P.). R.B. was a recipient of a postdoctoral fellowship of the University of Catania, Catania, Italy.
###end p 41
###begin title 42
REFERENCES
###end title 42
###begin p 43
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 472 474 472 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 531 532 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 541 543 536 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 579 580 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 589 591 572 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 594 595 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 629 630 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 641 643 613 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 667 668 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 679 681 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 683 684 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 720 721 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 732 734 690 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 736 737 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 760 761 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 770 772 728 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 796 797 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 806 808 764 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 842 843 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 852 854 800 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
Glucose, insulin, and derived indexes at OGTT in adult subjects. Glucose (A) and insulin (B) levels during OGTT in QQ (black triangles), KQ (gray circles), and KK (white circles) adult individuals. Insulinogenic index (C), insulin sensitivity index (ISI) (D), and disposition index (E) values in QQ (black bar), KQ (gray bar), and KK (white bar) adult individuals. All data were adjusted for sex, age, and BMI. A: Plasma glucose profiles in QQ vs. KK carriers, *P = 5 x 10-2. B: Plasma insulin levels at 30 min in QQ vs. KQ (daggerP = 2 x 10-4) and vs. KK carriers (double daggerP = 4 x 10-5). C: QQ vs. KQ carriers, section signP = 3.2 x 10-6; QQ vs. KK carriers, ||P = 2.2 x 10-7. D: KQ vs. KK carriers, paragraph signP = 3.6 x 10-2. E: KQ vs. KK carriers, #P = 3 x 10-2; QQ vs. KK carriers, **P = 4 x 10-4; QQ vs. KQ carriers, daggerdaggerP = 8 x 10-3.
###end p 43
###begin p 44
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 394 395 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 455 457 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 459 460 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 488 489 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 498 500 493 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#215;3</sup>
###xml 535 536 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 545 547 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 549 550 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 584 585 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 594 596 566 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 598 599 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 623 624 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 633 635 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 671 672 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 681 683 639 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 49 57 <span type="species:ncbi:9606">children</span>
Glucose, insulin, and derived indexes at OGTT in children. Glucose (A) and insulin (B) levels during OGTT in QQ (black triangles), KQ (gray circles), and KK (white circles) individuals. Insulinogenic index (C), insulin sensitivity index (ISI) (D), and disposition index (E) in KK (white bar), KQ (gray bar), and QQ (black bar) individuals. All data were adjusted for sex, age, and BMI z score. B: Plasma insulin levels in KQ vs. KK carriers, *P = 2.4 x 10-3. C: QQ vs. KQ carriers, daggerP = 7 x 10x3; QQ vs. KK carriers, double daggerP = 2 x 10-2. D: KQ vs. KK carriers, section signP = 6 x 10-3. E: QQ vs. KQ carriers, ||P = 2 x 10-2; QQ vs. KK carriers, paragraph signP = 7 x 10-3.
###end p 44
###begin p 45
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENPP1</italic>
Subjects clinical features and fasting biochemical parameters according to the ENPP1 K121Q polymorphism
###end p 45
###begin p 46
###xml 120 121 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
Data are means +/- SEM unless otherwise indicated. Significances are given after adjusting for age, sex, and BMI or BMI z score.
###end p 46
###begin p 47
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
P = 1.6 x 10-2 vs. KK adults and
###end p 47
###begin p 48
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 22 30 <span type="species:ncbi:9606">children</span>
P = 1.5 x 10-2 vs. KK children and adolescents. IRI, immunoreactive insulin.
###end p 48

